AEK-8213590-4/11/1

AbbVie Inc. — FEI 3009751352

Refusal Details

Date
March 4, 2025
Country
United States
Product Category
Drugs and Biologics
Product Code
66VIY99 MISCELLANEOUS PATENT MEDICINES, ETC.
Charges
75